Synergistic antiviral activity of gemcitabine and ribavirin against enteroviruses
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Kang, Hyunju | - |
dc.contributor.author | Kim, Chonsaeng | - |
dc.contributor.author | Kim, Dong-eun | - |
dc.contributor.author | Song, Jae-Hyoung | - |
dc.contributor.author | Choi, Miri | - |
dc.contributor.author | Choi, Kwangman | - |
dc.contributor.author | Kang, Mingu | - |
dc.contributor.author | Lee, Kyungjin | - |
dc.contributor.author | Kim, Hae Soo | - |
dc.contributor.author | Shin, Jin Soo | - |
dc.contributor.author | Kim, Janghwan | - |
dc.contributor.author | Han, Sang-Bae | - |
dc.contributor.author | Lee, Mi-Young | - |
dc.contributor.author | Lee, Su Ui | - |
dc.contributor.author | Lee, Chong-Kyo | - |
dc.contributor.author | Kim, Meehyein | - |
dc.contributor.author | Ko, Hyun-Jeong | - |
dc.contributor.author | van Kuppeveld, Frank J. M. | - |
dc.contributor.author | Cho, Sungchan | - |
dc.date.accessioned | 2021-08-11T19:24:40Z | - |
dc.date.available | 2021-08-11T19:24:40Z | - |
dc.date.issued | 2015-12 | - |
dc.identifier.issn | 0166-3542 | - |
dc.identifier.issn | 1872-9096 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/sch/handle/2021.sw.sch/10062 | - |
dc.description.abstract | Enteroviruses are major causative agents of various human diseases, and some of them are currently considered to be an enormous threat to public health. However, no effective therapy is currently available for the treatment of these infections. We identified gemcitabine, a nucleoside-analog drug used for cancer treatment, from a screen of bioactive chemicals as a novel inhibitor of coxsackievirus B3 (CVB3) and enterovirus 71 (EV71). Gemcitabine potently inhibited the proliferation of CVB3 and EV71, as well as the replication of CVB3 and EV71 replicons, in cells with a low micromolar IC50 (1-5 mu M). Its strong inhibitory effect was also observed in cells infected with human rhinoviruses, demonstrating broad-spectrum antiviral effects on enteroviruses. Mechanistically, an extensive analysis excluded the involvement of 2C, 3A, IRES-dependent translation, and also that of polyprotein processing in the antiviral effects of gemcitabine. Importantly, gemcitabine in combination with ribavirin, an antiviral drug currently being used against a few RNA viruses, exhibited a synergistic antiviral effect on the replication of CVB3 and EV71 replicons. Consequently, our results clearly demonstrate a new indication for gemcitabine as an effective broad-spectrum inhibitor of enteroviruses and strongly suggest a new therapeutic strategy using gemcitabine alone or in combination with ribavirin for the treatment of various diseases associated with enterovirus infection. (C) 2015 Elsevier B.V. All rights reserved. | - |
dc.format.extent | 10 | - |
dc.language | 영어 | - |
dc.language.iso | ENG | - |
dc.publisher | Elsevier BV | - |
dc.title | Synergistic antiviral activity of gemcitabine and ribavirin against enteroviruses | - |
dc.type | Article | - |
dc.publisher.location | 네델란드 | - |
dc.identifier.doi | 10.1016/j.antiviral.2015.10.011 | - |
dc.identifier.scopusid | 2-s2.0-84946198346 | - |
dc.identifier.wosid | 000370463200001 | - |
dc.identifier.bibliographicCitation | Antiviral Research, v.124, pp 1 - 10 | - |
dc.citation.title | Antiviral Research | - |
dc.citation.volume | 124 | - |
dc.citation.startPage | 1 | - |
dc.citation.endPage | 10 | - |
dc.type.docType | Article | - |
dc.description.isOpenAccess | N | - |
dc.description.journalRegisteredClass | sci | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Pharmacology & Pharmacy | - |
dc.relation.journalResearchArea | Virology | - |
dc.relation.journalWebOfScienceCategory | Pharmacology & Pharmacy | - |
dc.relation.journalWebOfScienceCategory | Virology | - |
dc.subject.keywordPlus | DEPENDENT RNA-POLYMERASE | - |
dc.subject.keywordPlus | ANTI-HIV-1 ACTIVITY | - |
dc.subject.keywordPlus | PROTEIN 3A | - |
dc.subject.keywordPlus | IN-VITRO | - |
dc.subject.keywordPlus | VIRUS | - |
dc.subject.keywordPlus | REPLICATION | - |
dc.subject.keywordPlus | INHIBITORS | - |
dc.subject.keywordPlus | RHINOVIRUS | - |
dc.subject.keywordPlus | COMBINATION | - |
dc.subject.keywordPlus | INFECTION | - |
dc.subject.keywordAuthor | Enteroviruses | - |
dc.subject.keywordAuthor | Antiviral inhibitor | - |
dc.subject.keywordAuthor | Gemcitabine | - |
dc.subject.keywordAuthor | Ribavirin | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(31538) 22, Soonchunhyang-ro, Asan-si, Chungcheongnam-do, Republic of Korea+82-41-530-1114
COPYRIGHT 2021 by SOONCHUNHYANG UNIVERSITY ALL RIGHTS RESERVED.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.